We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tate & Lyle Plc | LSE:TATE | London | Ordinary Share | GB00BP92CJ43 | ORD 29 1/6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.08% | 659.00 | 658.50 | 659.50 | 668.50 | 644.50 | 644.50 | 110,411 | 11:14:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Flavoring Extract,syrup, Nec | 1.65B | 188M | 0.4210 | 15.63 | 2.94B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/6/2021 13:42 | Some more digging on Ameriprise Financial. Scroll to the end of the Wiki page and you see that they have had to pay numerous fines up until recently so not exactly goody-two shoes but that aside i see that they were spun-out originally from American Express in 2005. 85% of revenues come from their wealth division which is under the Columbia Threadneedle management brand. Their third division is Riversource Life which is a seller of annuities. That leaves Ameriprise which business is mainly private client and retail brokerage services. Just a pure guess on my part because i have no clue but i still wonder if they are buying on behalf of a large client? If they were buying in their portfolio's then their new shareholding would fall under "Columbia Threadneedle" i would have thought. I might be wide of the mark but i suspect one way or the other all will be revealed perhaps in a few weeks time. | cfro | |
18/6/2021 14:41 | Maybe a full takeover if this drops much further | spoole5 | |
16/6/2021 18:09 | xd thursday. I think its usually, if not always, a thursday for all companies these days. The record date is friday, but that's irrelevant for us. | pierre oreilly | |
16/6/2021 16:47 | Ex-div date is actually next Friday with payment of 22p August 6th. What's going over and over in my mind is why Ameriprise Financial wants to own TATE. That is some jump in ownership going from 5.096% to over 10%. | cfro | |
16/6/2021 16:13 | That reminds me , 22p next Thursday. | wad collector | |
15/6/2021 14:57 | Will be closer to 7 after xd unless there's some sale news | spoole5 | |
14/6/2021 14:56 | Institutional buying: Blackrock above 5% and Ameriprise financial (never heard of them) whacking their stake up to over 10%. EDIT: Just doing some basic research on Ameriprise Financial and i see they are as you would a assume simply a financial advisory firm. Seems strange as to why they would want to own a large stake in TATE OR unless they are holding for a client? | cfro | |
10/6/2021 13:14 | Of course i didn't sell. It's now an income steam for me. Most think guessing a future price is worth gloating at. I think getting yourself a decent income stream is much more worth gloating at for those who like gloating. So you've given up trading now wad, and just hang on to what you've got for years? Much more sensible imv. (if you have decent shares). | pierre oreilly | |
10/6/2021 12:29 | Now no gloating Pierre , it was only there for half an hour and I bet you didn't sell! I think your opponent is a half-empty man by the look of it. | wad collector | |
04/6/2021 07:52 | Well, looks like we are going to the £8 target first.... | wad collector | |
28/5/2021 13:42 | Both those targets may be reached over the next few months of course.... | wad collector | |
28/5/2021 08:43 | No, there was no profit warning at all. A divi increase can be viewed as the opposite imv. Short it if you think this is going sub 7 quid. I've bought more because i think it'll soon be over 8 quid again, plus i'll get a decent divi every six months. Different opinions make the market. | pierre oreilly | |
28/5/2021 07:08 | If the split doesn't happen i can see this being sub 7 again | spoole5 | |
27/5/2021 10:37 | Don't agree with that spoole5 - my guess is they are just tempering expectations going forward. (The right thing to do imv.) Yes, some headwinds for sure but the eat out market opening up, new products coming and plenty of growth to go for will most likely see them upgrade forecasts as the financial year progresses. | cfro | |
27/5/2021 09:13 | Essentially a profits warning for 2022 | spoole5 | |
27/5/2021 08:35 | Split or no split TATE has an exciting future ahead imv. A split would be great but equally if it stayed as one then no matter as new management appointments have been made recently who will drive growth. The dividend increase says a lot about management and future prospects and will be well received in equal measures by shareholders. | cfro | |
27/5/2021 08:16 | Market seems unimpressed so far , currently down 40p. Bit more detail about the split plan: Discussions with potential new partners for Primary Products are ongoing. During the year, we incurred GBP19 million of exceptional costs, principally for external advisors, for work performed in relation to this potential transaction. There can be no certainty that a transaction will be concluded, and we will make further announcements when appropriate | wad collector | |
27/5/2021 08:03 | Philanderer, you sold the same time as i sold half my holding. Are you tempted back in? The divi increase is a big plus for me, other things i liked was the pandemic making more people health aware, which i suppose means more artificial sweenters, and the 'natural' trend where stavia will sell more. A safe plodder for the increasing (a bit surprisingly) divi. No furlows, no gov grants, don't know how they managed that. | pierre oreilly | |
27/5/2021 07:54 | Cheap enough for me to buy back in. Divi increase always cuts through all other waffle - that's how to tell what the directors really think of the future. | pierre oreilly | |
27/5/2021 07:01 | Forward looking statement wasn't that impressive. All eyes on the split now | spoole5 | |
27/5/2021 06:42 | PBT +6% Dilluted eps +12% final dividend +5.8% Good numbers. Primary products still delivered growth of +5% despite being hit by the out of home markets due to pandemic. Food and beverages solutions division up 12% - (you can see where the future growth is). No further info on the possible break-up but talks continuing. Sounds like the new investor for the primary products division has their own ideas of growing it as a seperate entity. I guess shareholders would get shares in the two companies. Sounds exciting if it goes ahead. | cfro | |
26/5/2021 08:18 | Full year results out tomorrow , doubt they will make any further comment on the reorganisation plans. | wad collector | |
06/5/2021 11:04 | Interesting new non-exec appointment too: Patrícia is currently Global Chief Marketing & Digital Officer of Bayer Consumer Health, and has built a career spanning 20 years in global consumer products. She has served as SVP and Chief Marketing Officer, Mexico for Heineken NV and held various global brand roles for Unilever as well as marketing roles for Kraft Foods and Tetra Pak International in Brazil. Shows the companies renewed focus on the food sciences division. | cfro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions